The global prevalence of diabetes is to rise from 171 million in 2000 to 366 million in 2030

India faces a grave health care burden due to high prevalence of Type-2 diabetes with its micro & Macrovascular complications.

As impaired glucose control is forerunner of diabetes it is essential to prevent high morbidity & mortality associated with diabetes by tight glycemic control with anti-hyperglycemic drugs.

Product List

  • 1 Glibenclamide Tablet 2.5mg / 5mg
    2 Metformin Tablet 500mg / 850mg
    3 Gliclazide Tablet 40mg / 80mg
    4 Glimepiride Tablet 1mg / 2mg / 3mg
    5 Pioglitazone Tablet 15mg / 30mg